Affiliate disclosure: some links on this page are affiliate links and may earn us a commission at no extra cost to you — it never affects our rankings or reviews.

Comparison · United States

Foundayo vs Zepbound: cost, weight loss and how they differ

Paying cash at the starting dose, Foundayo starts at $149 a month (Hims, LillyDirect and Ro.co) and Zepbound at $299 a month (Hims, LillyDirect and Ro.co), checked November 19, 2026. Both are made by Lilly. Foundayo (orforglipron) is a pill taken once a day, with or without food[1]; Zepbound (tirzepatide) is an injection taken once a week, with no pill form[3]. In their own 72-week trials, average weight loss was up to 11.1% on Foundayo[1] and up to 20.9% on Zepbound[6], in separate trials rather than head to head. Which suits you is a decision to make with a clinician.

Edited by Gabriel BrocklesbyFounder & EditorFact-checkedLast updated

Label, approval and trial facts checked against the sources listed below on November 9, 2026. Prices read from each seller's own page, last read November 19, 2026. Informational only, not medical advice.

Foundayo vs Zepbound at a glance

 FoundayoZepbound
Active ingredientOrforglipron (Eli Lilly)[1]Tirzepatide (Eli Lilly)[3]
How it worksA GLP-1 receptor agonist: binds to and activates the GLP-1 receptor[1]Acts on two receptors: GIP and GLP-1[3]
FDA approval for weight managementApril 1, 2026[2]November 8, 2023[4]
Form and scheduleA tablet once a day, with or without food, swallowed whole[1]An injection once a week: single-dose pen, KwikPen or vial. No pill[3]
Label dose rangeStarts at 0.8 mg a day, then 2.5 mg and 5.5 mg after at least 30 days each; may go up to 9 mg, 14.5 mg or 17.2 mg a day[1]Starts at 2.5 mg a week, raised in steps of at least 4 weeks; maintenance 5, 10 or 15 mg a week[3]
Other FDA approved usesNone listed beyond weight management[1]Moderate to severe obstructive sleep apnea in adults with obesity (approved December 20, 2024)[5],[3]
Average weight loss, own pivotal trial7.4%, 8.3% and 11.1% at 72 weeks on 5.5, 9 and 17.2 mg, against 2.1% on placebo[1]15.0%, 19.5% and 20.9% at 72 weeks on 5, 10 and 15 mg, against 3.1% on placebo (SURMOUNT-1)[6]

Foundayo vs Zepbound cost without insurance

Starting-dose medicine prices, read from each seller's own pricing page. LillyDirect is Lilly's own self-pay pharmacy: it prints no membership and needs a prescription you already hold. The telehealth programs supply the clinician and the prescription and bill a membership on top. A prescription is decided by a licensed clinician and is never guaranteed.

Foundayo cash prices

Foundayo cash prices at the starting dose, by seller
SellerFormCash priceMembership or extra feesChecked
HimsTelehealth programSee Hims pricingPill$149/moMembership $149/mo month to month, $39 the first month, billed separatelyNov 19, 2026
LillyDirectManufacturer self-payPill$149/moNo membership printed, prescription requiredNov 16, 2026
Ro.coTelehealth programSee Ro.co pricingPill$149/moMembership $149/mo month to month, $39 the first month, plan rates from $74/mo, billed separatelyNov 19, 2026

Zepbound cash prices

Zepbound cash prices at the starting dose, by seller
SellerFormCash priceMembership or extra feesChecked
HimsTelehealth programSee Hims pricingKwikPen (multi-dose pen)$299/moMembership $149/mo month to month, $39 the first month, billed separatelyNov 19, 2026
HimsTelehealth programSee Hims pricingVial$299/moMembership $149/mo month to month, $39 the first month, billed separatelyNov 19, 2026
LillyDirectManufacturer self-payKwikPen (multi-dose pen)$299/moNo membership printed, pen needles sold separately, prescription requiredNov 19, 2026
LillyDirectManufacturer self-payVial$299/moNo membership printed, needles and syringes sold separately, prescription requiredNov 19, 2026
Ro.coTelehealth programSee Ro.co pricingKwikPen (multi-dose pen)$299/moMembership $149/mo month to month, $39 the first month, plan rates from $74/mo, billed separatelyNov 19, 2026

Prices rise with the dose:

  • LillyDirect, Foundayo: $149/mo at 0.8 mg; $149/mo at 2.5 mg; $199/mo at 5.5 mg; $299/mo at 9 mg; $299/mo at 14.5 mg and 17.2 mg (checked Nov 16, 2026). Lilly says the 2.5 mg and 5.5 mg prices are temporarily reduced through December 31, 2026, and the 14.5 mg and 17.2 mg price applies when you refill within 45 days.
  • Ro: Foundayo pill (daily orforglipron): $149 at 0.8 mg (checked Nov 19, 2026); $149 at 2.5 mg under an offer for sign-ups by December 31, 2026 (standard $199) (checked Nov 19, 2026); $199 at 5.5 mg under an offer for sign-ups by December 31, 2026 (standard $299) (checked Nov 19, 2026); $299 at 9 mg (checked Nov 18, 2026); $299 at 14.5 mg and 17.2 mg (checked Nov 18, 2026).
  • Ro: Zepbound KwikPen (weekly tirzepatide injection): $299 at 2.5 mg (checked Nov 19, 2026); $399 at 5 mg (checked Nov 18, 2026); $449 at 7.5 mg (checked Nov 18, 2026); $449 at 10 mg to 15 mg (checked Nov 18, 2026).

For every brand-name seller and its price history, see the brand-name GLP-1 price chart, Foundayo cost without insurance and Zepbound cost without insurance.

Weight loss: what the trials found

Foundayo's main trial enrolled 3,127 adults with obesity, or with overweight and a weight-related condition, without type 2 diabetes. After 72 weeks, average weight loss was 7.4% on 5.5 mg, 8.3% on 9 mg and 11.1% on 17.2 mg, against 2.1% on placebo[1].

In Zepbound's main trial, SURMOUNT-1, average weight loss at 72 weeks was 15.0%, 19.5% and 20.9% on 5, 10 and 15 mg, against 3.1% on placebo[6].

No trial in these sources has compared the two directly. The trials ran at different times and in different people, so their numbers are not a head-to-head comparison. Every figure is an average, not a prediction for any one person.

Foundayo vs the Wegovy pill

The other FDA-approved GLP-1 pill for weight management is the Wegovy pill (oral semaglutide, Novo Nordisk). It is taken each morning on an empty stomach with up to 4 ounces of water, at least 30 minutes before eating[8]; Foundayo can be taken with or without food[1]. On the 25 mg Wegovy pill, average weight loss was 13.6% at 64 weeks, against 2.2% on placebo[7]. Paying cash at the starting dose, Foundayo starts at $149/mo and the Wegovy pill at $149/mo (checked Nov 19, 2026). Every pill, by seller, is on the GLP-1 pills guide.

Who sells each online

Online programs that prescribe brand-name Foundayo and Zepbound, from our price archive. Each runs its own clinician review, and its membership is billed separately. LillyDirect sells both to self-pay patients who already hold a prescription.

Frequently asked questions

Is Foundayo as effective as Zepbound?

No trial in the sources on this page has compared them directly. In their own placebo-controlled trials, both 72 weeks long, average weight loss on Foundayo was 7.4%, 8.3% and 11.1% on 5.5, 9 and 17.2 mg, against 2.1% on placebo, and on Zepbound 15.0%, 19.5% and 20.9% on 5, 10 and 15 mg, against 3.1% on placebo (SURMOUNT-1). The trials enrolled different people at different times, so these are averages, not a head-to-head result or a prediction for any one person.

How much does Foundayo cost without insurance?

Paying cash, Foundayo starts at $149 a month at the starting dose (Hims, LillyDirect and Ro.co, checked Nov 19, 2026). The price rises with the dose. Telehealth programs bill a membership on top; LillyDirect needs a prescription you already hold.

Is Foundayo cheaper than Zepbound?

At the starting dose, Foundayo costs less than Zepbound. Foundayo starts at $149 a month and Zepbound at $299 a month, paying cash (checked Nov 19, 2026). Both cost more at higher doses.

Foundayo vs the Wegovy pill: what is the difference?

Both are once-daily GLP-1 pills approved for weight management. Foundayo (orforglipron, Lilly) can be taken with or without food; the Wegovy pill (semaglutide, Novo Nordisk) is taken on an empty stomach in the morning with up to 4 ounces of water, at least 30 minutes before eating. On the 25 mg Wegovy pill, average weight loss was 13.6% at 64 weeks against 2.2% on placebo (OASIS 4). Paying cash at the starting dose, Foundayo starts at $149 a month and the Wegovy pill at $149 a month (checked Nov 19, 2026).

Is Foundayo FDA approved?

Yes. The FDA approved Foundayo (orforglipron) on April 1, 2026, for weight reduction and long-term maintenance in adults with obesity, or with overweight and at least one weight-related condition, alongside a reduced-calorie diet and more physical activity. It needs a prescription.

Can I switch from Zepbound to Foundayo?

Switching is a prescriber's decision. The two have different active ingredients, different forms and different dose schedules, so a switch is not a like-for-like swap, and the dose to start on is set by your clinician.

Comparing two injections instead? See Zepbound vs Wegovy.

Sources

  1. Foundayo (orforglipron) tablets, US prescribing information, revised July 2026, Eli Lilly. Read November 9, 2026.
  2. Lilly Medical: Is Foundayo (orforglipron) approved and is it available? (FDA approval April 1, 2026; available through LillyDirect, telehealth providers and US retail pharmacies). Read November 9, 2026.
  3. Zepbound (tirzepatide) injection, US prescribing information, revised August 2026, DailyMed. Read November 5, 2026.
  4. Drugs@FDA, NDA 217806 (Zepbound, Eli Lilly): original approval November 8, 2023. Read November 5, 2026.
  5. FDA news release, December 20, 2024: FDA Approves First Medication for Obstructive Sleep Apnea (Zepbound). Read November 5, 2026.
  6. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine 2022;387:205-216, PubMed 35658024. Adults with obesity, or overweight with a weight-related complication, without diabetes; 72 weeks. Read November 5, 2026.
  7. Wharton S et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4). New England Journal of Medicine 2025;393(11):1077-1087, PubMed 40934115. 307 adults without diabetes, once daily, 64 weeks. Funded by Novo Nordisk. Read November 5, 2026.
  8. Wegovy (semaglutide) injection and Wegovy (semaglutide) tablets, US prescribing information, revised June 2026, DailyMed. Read November 5, 2026.

Prices: each seller's own pricing page, read on the date shown beside the price.